USPTO serial 79399821
ENDOSTARSIL HEMOSTAT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 19, 2025
- Examiner
- NODES, CHRISTOPHER JAMES
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ENDOSTARSIL HEMOSTAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bryan W. Bockhop
Bryan W. Bockhop Bockhop Intellectual Property Law, LLC6234 Old Highway 5 Ste D9PMB 195Woodstock, GA 30188Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical tissues, namely, surgical implants comprising living tissues; haemostatic preparations, namely, pharmaceutical preparations being hemostatic agents for blood clotting; antihaemophilic factor, namely, pharmaceutical preparations for treating hemophilia; pharmaceutical preparations, namely, blood clotting powder; medical dressing with blood clotting properties; pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; medical plasters, medical dressings, namely, materials for medical dressings; medical dressings; surgical dressings; absorbable surgical dressings; blood clotting, absorbable surgical dressings | ACTIVE | — |
| 010 | Medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; orally inserted medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; medical and veterinary endoscopes for colonoscopy for introducing blood clotting agents and blood clotting powder into the human or animal body | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hemostat Manufacturing GmbH
- Other trademarks owned by Hemostat Manufacturing GmbH
- Other trademarks owned by Hemostat Manufacturing GmbH
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ENDOSTARSIL HEMOSTAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 2, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 2, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 25, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 10, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 10, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 19, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 19, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 1, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 30, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 30, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 30, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 24, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 24, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 31, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 30, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |